Log in to save to my catalogue

An international working group consensus report for the prioritization of molecular biomarkers for E...

An international working group consensus report for the prioritization of molecular biomarkers for E...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d5d49a92054aefa68b0e44c262da64

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

About this item

Full title

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

Publisher

London: Nature Publishing Group UK

Journal title

NPJ precision oncology, 2022-09, Vol.6 (1), p.65-11, Article 65

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60–80% of patients with metastatic tumors suffer relapse and die of disease. In addition, those who survive are often left with...

Alternative Titles

Full title

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85d5d49a92054aefa68b0e44c262da64

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d5d49a92054aefa68b0e44c262da64

Other Identifiers

ISSN

2397-768X

E-ISSN

2397-768X

DOI

10.1038/s41698-022-00307-2

How to access this item